Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06554028
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced LaryngealHypopharyngeal Cancer
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: